Alan L. Crane, Director at MOMENTA PHARMACEUTICALS INC (MNTA), sold 50,000 shares at $17.44 ($880K) on 2006-12-08, disclosed to the SEC on 2006-12-12.
Scheduled sale ($880k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.44 | 100 | $2K | 0.2% |
| 2 | $17.46 | 24,969 | $436K | 49.6% |
| 3 | $17.47 | 200 | $3K | 0.4% |
| 4 | $17.48 | 400 | $7K | 0.8% |
| 5 | $17.49 | 100 | $2K | 0.2% |
| 6 | $17.51 | 371 |
| $6K |
| 0.7% |
| 7 | $17.55 | 100 | $2K | 0.2% |
| 8 | $17.56 | 100 | $2K | 0.2% |
| 9 | $17.60 | 1,600 | $28K | 3.2% |
| 10 | $17.61 | 100 | $2K | 0.2% |
| 11 | $17.68 | 500 | $9K | 1.0% |
| 12 | $17.70 | 7,800 | $138K | 15.7% |
| 13 | $17.75 | 4,100 | $73K | 8.3% |
| 14 | $17.77 | 655 | $12K | 1.3% |
| 15 | $17.78 | 267 | $5K | 0.5% |
| 16 | $17.80 | 8,082 | $144K | 16.4% |
| 17 | $17.84 | 556 | $10K | 1.1% |
| Total | $17.59 avg | 50,000 | $880K | 100% |
| Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |
| MNTA | SELL | 2007-01-12 | $873K | — | Filing → |
| MNTA | SELL | 2006-12-20 | $1.0M | — | Filing → |